Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839289 · ClinicalTrials.gov registry record · NA
Hearing Aid Signal Processing Comparative Study
A NA study, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04839289 is a NA study that has completed, run by Sonova. The registered enrollment target is 27 participants.
The verdict
NCT04839289, a NA study, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their preference for each hearing instrument.
Interventions
- DEVICE Receiver-in-canal hearing instrument; Manufacturer A
- DEVICE Receiver-in-canal hearing instrument; Manufacturer B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04839289
The ClinicalTrials.gov registry entry for NCT04839289 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonova, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Receiver-in-canal hearing instrument; Manufacturer A is the first listed.
NCT04839289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04839289 about?
NCT04839289 is a clinical study titled "Hearing Aid Signal Processing Comparative Study". Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their ...
What is the current status of trial NCT04839289?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-07-01. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT04839289?
The interventions under investigation include: Receiver-in-canal hearing instrument; Manufacturer A (DEVICE), Receiver-in-canal hearing instrument; Manufacturer B (DEVICE).
Who is sponsoring clinical trial NCT04839289?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.